Direxion Daily S&P Biotech Bear 3X ETF (LABD)
Direxion Daily S&P Biotech Bear 3X ETF operates in the Asset Management - Leveraged industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $7.28, down 2.67% on the session, giving a market capitalisation of $16.6M. Its beta of -3.32 implies it has historically moved less than the broad market.
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. It's important to note, however, that there is no assurance these funds will successfully achieve their intended daily objectives.
Direxion Daily S&P Biotech Bear 3X ETF is most often compared with the following Financial Services names: